Studies have shown that active fund managers routinely underperform the S&P500 index*​

InspireMD, Inc. (NASDAQ: NSPR)

NSPR Stock Predictions and Ratings

WSX Rating:
STRONG BUY
WSX Forecast (1yr):
99.90%
Analyst Rating:
BUY
Analyst Forecast (1yr):
56.20%

NSPR Stock Analysis

NSPR PE Ratio:

NSPR PEG Ratio: Not Available

NSPR Forward EPS Growth (12 month): 0.00%

NSPR PS Ratio: 4.3

NSPR PSG Ratio:

NSPR Forward Revenue Growth (12 month): 106.00%

NSPR Articles

No data was found